000			03597nam a22003855i 4500
999			_c368783 _d368783 _x1
001			368783
003			ES-MaUEC
005			20230102121807.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			220210s2022 sz | s |||| 0|eng d
020			_a9783030900656
024	7		_a10.1007/978-3-030-90065-6 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRA644. C67 _b2022 EB
100	1		_aMallick, Umair _eautor _9683585
245	1	0	_aCardiovascular Complications of COVID-19 : _bRisk, Pathogenesis and Outcomes _cby Umair Mallick
250			_aFirst edition 2022
264		1	_aCham _bSpringer International Publishing _c2022
300			_a1 recurso en línea (X, 414 páginas) _b87 ilustraciones, 69 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aarchivo de texto _bPDF
505	0		_aEpidemiology -- Virology Of COVID 19 -- Clinical Features And Complications Of COVID 19.-Treatment Options In Covid 19 -- Inflammation And COVID 19 -- Renin Angiotensin System And COVID 19 -- Pathogenetic Mechanisms In Non-Cardiovascular Complications -- Cytokines And Viral Damage In COVID 19 -- Thrombosis In COVID 19 -- Angiotensin Converting Enzyme 2 In COVID 19 -- Regulatory Systems And COVID 19 -- Miscellaneous Novel Mechanisms In COVID 19 -- Myocardial Injury And Acute Coronary Syndromes In COVID 19 -- Heart Failure, Hypertension And Arrhythmias In COVID 19 -- Patients With Cardiometabolic Diseases And COVID 19 -- Older Age And COVID 19 -- Gender Dichotomy And COVID 19 -- Quality Of Research In COVID 19 -- Conclusion.
520			_aThis book discusses the evidence behind the relationship between COVID-19 and heart disease based on emerging state-of-the-art data. The rapid and unexpected global spread of the COVID-19 has revealed proportional levels of cardiovascular and metabolic complications. A myriad of pathogenetic mechanisms has come to the surface. There is still much research required to define whether cardiovascular disease causes COVID-19 complications or that cardiovascular disease appears as a result of the infection and which mechanisms are responsible. With cardiovascular and metabolic diseases already at pandemic levels and expected to increase further, this book provides readers with an urgent and thorough analysis of this association. Cardiovascular Complications of COVID-19: Risk, Pathogenesis and Outcomes provides answers to the increasing numbers of questions related to heart disease in COVID-19, highlighting the association between these pandemics and including risk factors, mechanisms and how these may impact diverse patients populations. It describes how COVID-19 impacts older patients and those with metabolic illnesses such as obesity and diabetes mellitus, while providing an overview of the observed gender dichotomy among patients. It therefore represents an essential resource not only for all cardiovascular physicians but also for any healthcare professionals managing patients with these diseases or those exploring COVID-19.
988			_aSpringer_Medicine_2022
650		7	_2embne _aCOVID-19 _9683668
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-90065-6 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE _n0
998			_b04/2022 _dz _eu _zSI